Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus
Fanny Georgi, Vardan Andriasyan, Robert Witte, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 9
Open Access | Times Cited: 22

Showing 22 citing articles:

Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment
Joseph P. Lynch, Adriana E. Kajon
Seminars in Respiratory and Critical Care Medicine (2021) Vol. 42, Iss. 06, pp. 800-821
Closed Access | Times Cited: 64
Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies
Mackenzie J. Dodge, Katelyn M. MacNeil, Tanner M. Tessier, et al.
Antiviral Research (2021) Vol. 188, pp. 105034-105034
Open Access | Times Cited: 57
Adenoviruses in medicine: innocuous pathogen, predator, or partner
Katelyn M. MacNeil, Mackenzie J. Dodge, Andris M. Evans, et al.
Trends in Molecular Medicine (2022) Vol. 29, Iss. 1, pp. 4-19
Open Access | Times Cited: 39
Viral proteases as therapeutic targets
Taťána Majerová, Jan Konvalinka
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101159-101159
Open Access | Times Cited: 34
Virus Infection Variability by Single-Cell Profiling
Maarit Suomalainen, Urs F. Greber
Viruses (2021) Vol. 13, Iss. 8, pp. 1568-1568
Open Access | Times Cited: 39
Adenovirus – a blueprint for gene delivery
Urs F. Greber, Alfonso Gómez-González
Current Opinion in Virology (2021) Vol. 48, pp. 49-56
Open Access | Times Cited: 37
Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern
Luca Murer, Romain Volle, Vardan Andriasyan, et al.
Current Research in Virological Science (2022) Vol. 3, pp. 100019-100019
Open Access | Times Cited: 26
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
Anthony Petkidis, Vardan Andriasyan, Luca Murer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
The role of weak interactions in evaluation of inhibitory potential of Indinavir as an HIV protease inhibitor and its comparison with innovative drug candidates
Mehdi Yoosefian, Hanieh Sabaghian
Computers in Biology and Medicine (2025) Vol. 187, pp. 109675-109675
Closed Access
Microscopy deep learning predicts virus infections and reveals mechanics of lytic-infected cells
Vardan Andriasyan, Artur Yakimovich, Anthony Petkidis, et al.
iScience (2021) Vol. 24, Iss. 6, pp. 102543-102543
Open Access | Times Cited: 27
Recent Advances in Novel Antiviral Therapies against Human Adenovirus
Bratati Saha, Robin J. Parks
Microorganisms (2020) Vol. 8, Iss. 9, pp. 1284-1284
Open Access | Times Cited: 26
Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating
Luca Murer, Anthony Petkidis, Thomas Vallet, et al.
Journal of Virology (2021) Vol. 96, Iss. 2
Open Access | Times Cited: 15
A high-content image-based drug screen of clinical compounds against cell transmission of adenovirus
Fanny Georgi, Fabien Kuttler, Luca Murer, et al.
Scientific Data (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 15
In vitro assessment of the anti-adenoviral activity of artemisinin and its derivatives
Diyuan Yang, Jing Ning, Yuyu Zhang, et al.
Virus Research (2024) Vol. 349, pp. 199448-199448
Open Access | Times Cited: 1
Current antiviral agents against human adenoviruses associated with respiratory infections
Lexi Li, Zhengde Xie, Lili Xu
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1
High-content, arrayed compound screens with rhinovirus, influenza A virus and herpes simplex virus infections
Dominik Olszewski, Fanny Georgi, Luca Murer, et al.
Scientific Data (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Identification of Broad Anti-Coronavirus Chemical Agents for Repurposing Against SARS-CoV-2 and Variants of Concern
Luca Murer, Romain Volle, Vardan Andriasyan, et al.
SSRN Electronic Journal (2021)
Open Access | Times Cited: 4
Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management
Christos Papaneophytou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8105-8105
Open Access
Antiviral history and viral targets for antiviral therapy
Akram Hegazy, Sara H. Mahmoud, Ahmed Magdy Khalil, et al.
Elsevier eBooks (2024), pp. 219-275
Closed Access
Selenadiazole Inhibited Adenovirus-Induced Apoptosis through the Oxidative-Damage-Mediated Bcl-2/Stat 3/NF-κB Signaling Pathway
Xia Liu, Jia Lai, Jingyao Su, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1474-1474
Open Access | Times Cited: 1
Human Adenovirus Type 5 Infection Leads to Nuclear Envelope Destabilization and Membrane Permeability Independently of Adenovirus Death Protein
Søren Pfitzner, Jens B. Bosse, Helga Hofmann-Sieber, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13034-13034
Open Access | Times Cited: 3
Arrayed multicycle drug screens identify broadly acting chemical inhibitors for repurposing against SARS-CoV-2
Luca Murer, Romain Volle, Vardan Andriasyan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Page 1

Scroll to top